Compugen (CGEN) Revenue & Revenue Breakdown
Compugen Revenue Highlights
Latest Revenue (Y)
$33.46M
Latest Revenue (Q)
$2.56M
Main Geography (Y)
Unites States
Compugen Revenue by Period
Compugen Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $33.46M | 346.12% |
2022-12-31 | $7.50M | 25.00% |
2021-12-31 | $6.00M | 200.00% |
2020-12-31 | $2.00M | 100.00% |
2019-12-31 | - | -100.00% |
2018-12-31 | $17.80M | 100.00% |
2017-12-31 | - | -100.00% |
2016-12-31 | $712.00K | -92.33% |
2015-12-31 | $9.28M | -24.99% |
2014-12-31 | $12.37M | 248.46% |
2013-12-31 | $3.55M | 1366.53% |
2012-12-31 | $242.00K | 100.00% |
2011-12-31 | - | -100.00% |
2010-12-31 | $1.11M | 346.00% |
2009-12-31 | $250.00K | -26.04% |
2008-12-31 | $338.00K | 87.78% |
2007-12-31 | $180.00K | -16.28% |
2006-12-31 | $215.00K | -66.72% |
2005-12-31 | $646.00K | -83.96% |
2004-12-31 | $4.03M | -54.37% |
2003-12-31 | $8.83M | -20.46% |
2002-12-31 | $11.10M | -2.32% |
2001-12-31 | $11.36M | 64.85% |
2000-12-31 | $6.89M | 112.88% |
1999-12-31 | $3.24M | - |
Compugen Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $2.56M | -92.35% |
2023-12-31 | $33.46M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | -100.00% |
2022-12-31 | $7.50M | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | -100.00% |
2021-09-30 | $6.00M | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | -100.00% |
2020-12-31 | $2.00M | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | -100.00% |
2018-09-30 | $7.80M | 100.00% |
2018-06-30 | - | -100.00% |
2018-03-31 | $10.00M | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | -100.00% |
2016-12-31 | $53.00K | -24.29% |
2016-09-30 | $70.00K | -85.89% |
2016-06-30 | $496.00K | 433.33% |
2016-03-31 | $93.00K | -98.88% |
2015-12-31 | $8.31M | 3530.13% |
2015-09-30 | $229.00K | 2.69% |
2015-06-30 | $223.00K | -56.53% |
2015-03-31 | $513.00K | -92.17% |
2014-12-31 | $6.55M | 281.37% |
2014-09-30 | $1.72M | -12.53% |
2014-06-30 | $1.96M | -7.92% |
2014-03-31 | $2.13M | 20.17% |
2013-12-31 | $1.77M | 11.64% |
2013-09-30 | $1.59M | 7127.27% |
2013-06-30 | $22.00K | -86.42% |
2013-03-31 | $162.00K | 20.90% |
2012-12-31 | $134.00K | 24.07% |
2012-09-30 | $108.00K | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2011-09-30 | - | 100.00% |
2011-06-30 | - | 100.00% |
2011-03-31 | - | -100.00% |
2010-12-31 | $190.00K | 100.00% |
2010-09-30 | - | -100.00% |
2010-06-30 | $800.00K | 540.00% |
2010-03-31 | $125.00K | 400.00% |
2009-12-31 | $25.00K | 100.00% |
2009-09-30 | - | -100.00% |
2009-06-30 | $225.00K | 100.00% |
2009-03-31 | - | -100.00% |
2008-12-31 | $11.00K | 83.33% |
2008-09-30 | $6.00K | -85.00% |
2008-06-30 | $40.00K | -85.77% |
2008-03-31 | $281.00K | 212.22% |
2007-12-31 | $90.00K | - |
Compugen Revenue Breakdown
Compugen Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 18 |
---|---|---|---|---|---|
Europe | $10.00M | $7.50M | $6.00M | $2.00M | $17.80M |
Unites States | $23.46M | - | - | - | - |
Latest
Compugen Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
BEAM | Beam Therapeutics | $377.71M | $14.27M |
CRBU | Caribou Biosciences | $34.48M | $3.46M |
CGEN | Compugen | $33.46M | $2.56M |
ICCC | ImmuCell | $17.47M | $6.01B |
ITOS | iTeos Therapeutics | $12.60M | $35.00M |
CLGN | CollPlant Bio | $10.96M | $98.00K |
EVGN | Evogene | $5.64M | $4.19M |
BLRX | BioLineRx | $4.80M | $6.86M |
PLUR | Pluri | $326.00K | $96.00K |
ALLO | Allogene Therapeutics | $95.00K | - |
EDIT | Editas Medicine | - | - |
ANNX | Annexon | - | - |
SANA | Sana Bio | - | - |